News | May 03, 2024
Novartis to acquire Mariana Oncology for upfront US$ 1 billion
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Pharma Solutions operates 10 research and development and/or production sites globally
The pilot plant is focused on scaling up beverage production and will support applications
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
The investment will catalyse various components of the IndiaAI Mission
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
Subscribe To Our Newsletter & Stay Updated
